Complicated Supercomplexes

Molecular details of how proteins interact to repair DNA breaks reveal complexities that underlie their tumor-suppressive effects in different cancers. In the world of genome repair analysis, much attention has been focused on the mechanism underlying error-free repair of DNA double-strand breaks. This process, which involves homologous recombination— based repair, warrants close attention, not least because failure to repair double-strand breaks can be lethal. Similarly, disorderly repair can result in loss of chromosomal integrity and spur tumor development. Three recent studies emphasize the complex nature of the suspected link between the homologous recombination mechanism in mammalian cells and the suppression of cancer.

[1]  Junjie Chen,et al.  PALB2 is an integral component of the BRCA complex required for homologous recombination repair , 2009, Proceedings of the National Academy of Sciences.

[2]  Alison P. Klein,et al.  Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.

[3]  Feng Zhang,et al.  PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response , 2009, Current Biology.

[4]  W. Foulkes,et al.  Hereditary breast cancer: new genetic developments, new therapeutic avenues , 2008, Human Genetics.

[5]  Petra M. Nederlof,et al.  Analysis of PALB2/FANCN-associated breast cancer families , 2007, Proceedings of the National Academy of Sciences.

[6]  Katri Pylkäs,et al.  A recurrent mutation in PALB2 in Finnish cancer families , 2007, Nature.

[7]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.

[8]  Hans Joenje,et al.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 , 2007, Nature Genetics.

[9]  S. Seal,et al.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.

[10]  C. Mathew,et al.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.

[11]  F. Couch,et al.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.

[12]  R. Greenberg,et al.  Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. , 2006, Genes & development.

[13]  F. Couch,et al.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. , 1998, Molecular cell.